Skip to main content

Table 1 Antibacterial activity of the biosurfactant extracts (1.00 mg mL−1) against a panel of Gram-negative and Gram-positive bacterial isolates

From: Characterisation and antimicrobial activity of biosurfactant extracts produced by Bacillus amyloliquefaciens and Pseudomonas aeruginosa isolated from a wastewater treatment plant

Organism (strain number)

Source

Antibacterial inhibition zone diameter (mm) ± SD

Surfactin extract

(0.26 ± 0.09 mg mL−1)

Rhamnolipid extract

(1.12 ± 0.08 mg mL−1)

Gram-negative target organism

 Escherichia coli (ATCC 417373)

ATCC

13 ± 0

13.5 ± 0.4

 E. coli (ATCC 13706)

ATCC

10 ± 0

29.3 ± 0.9

 Enteroinvasive E. coli (ATCC 43892)

ATCC

15 ± 0

22.7 ± 2.1

 GEnteropathogenic E. coli (B170)

ATCC

18.3 ± 0.5

20.3 ± 0.5

 Enterohaemorhagic E. coli (O157:H7)

ATCC

13.7 ± 0.5

13.7 ± 0.5

 Enterotoxigenic E. coli (H10407)

ATCC

17.7 ± 1.2

13 ± 0

 Enteroaggregative E. coli (3591-87)

ATCC

12.3 ± 0.5

24.3 ± 1.2

 Klebsiella pneumoniae (ATCC 10031)

ATCC

14 ± 1.6

13.5 ± 0.5

 Salmonella typhimurium (ATCC 14028)

ATCC

25.3 ± 1.2

20.3 ± 0.5

 Serratia marcescens (ATCC 13880)

ATCC

12.7 ± 0.9

14 ± 0

 K. pneumoniae (P2)

Clinical

13 ± 0.8

11.7 ± 0.9

 K. pneumoniae (P3)

Clinical

13.3 ± 0.2

8.3 ± 0.5

 Salmonella enterica (SE19)

Environment

12.5 ± 0.5

14 ± 0

 Acinetobacter sp. (F1S6)

Environment

12.3 ± 0.5

13 ± 1.4

 Serratia sp. (SM14)

Environment

11.7 ± 0.9

14.3 ± 1.2

 Serratia sp. (L8)

Environment

12.5 ± 0.5

9.8 ± 0.8

 Enterobacter sp. (E11)

Environment

11.3 ± 0.5

13 ± 0.8

 Enterobacter sp. (E22)

Environment

14.2 ± 0.6

13 ± 0.8

 E. coli (K4CCA)

Environment

14.5 ± 0.5

17.7 ± 1.9

 K. pneumoniae (k2a)

Environment

15.3 ± 0.5

13.7 ± 0.5

Gram-positive target organism

 O Staphylococcus aureus (ATCC 25923)

ATCC

14.7 ± 0.5

13.7 ± 0.5

 B. cereus (ATCC 10876)

ATCC

10.3 ± 0.5

13 ± 0.8

 B. cereus (LMG 13569)

ATCC

13 ± 0.8

17 ± 1.4

 Enterococcus faecalis (S1)

Clinical

18.7 ± 0.9

10.7 ± 0.5

 Enterococcus faecalis (S2)

Clinical

18.3 ± 1.2

21.7 ± 2.4

 G,O,P,TMRSA (Xen 30)

Clinical

15.3 ± 0.5

13.3 ± 0.5

 Bacillus cereus (ST18)

Environment

Inactive

22.3 ± 0.9

 Enterococcus sp. (C513)

Environment

12.3 ± 0.5

15.7 ± 0.5

 Micrococcus sp. (AQ4S2)

Environment

14 ± 0

14 ± 1

 S. aureus (C2)

Environment

11.5 ± 0.5

14 ± 0

 S. aureus (C3)

Environment

12 ± 0

11 ± 0

  1. The surfactin and rhamnolipid extracts were observed to be at 32.8 and 34.4% purity, respectively
  2. Values are the means ± standard deviations (SD) of triplicate measurements; ATCC American Type Culture, O resistant to Oxacillin, G resistant to Gentamicin, T resistant to Tetracycline, P resistant to Penicillin G